Cargando…

Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections in the elderly and in children, associated with pediatric hospitalizations. Recently, first vaccines have been approved for people over 60 years of age applied by intramuscular injection. However, a vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eberlein, Valentina, Ahrends, Mareike, Bayer, Lea, Finkensieper, Julia, Besecke, Joana Kira, Mansuroglu, Yaser, Standfest, Bastian, Lange, Franziska, Schopf, Simone, Thoma, Martin, Dressman, Jennifer, Hesse, Christina, Ulbert, Sebastian, Grunwald, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535182/ https://www.ncbi.nlm.nih.gov/pubmed/37766253 http://dx.doi.org/10.3390/v15091846

Ejemplares similares

Low-Energy Electron Irradiation of Tick-Borne Encephalitis Virus Provides a Protective Inactivated Vaccine
por: Finkensieper, Julia, et al.
Publicado: (2022)

Apicomplexan parasites are attenuated by low-energy electron irradiation in an automated microfluidic system and protect against infection with Toxoplasma gondii
por: Finkensieper, Julia, et al.
Publicado: (2023)

Automated application of low energy electron irradiation enables inactivation of pathogen- and cell-containing liquids in biomedical research and production facilities
por: Fertey, Jasmin, et al.
Publicado: (2020)

Publisher Correction: Automated application of low energy electron irradiation enables inactivation of pathogen- and cell-containing liquids in biomedical research and production facilities
por: Fertey, Jasmin, et al.
Publicado: (2020)

Low-Energy Electron Irradiation Efficiently Inactivates the Gram-Negative Pathogen Rodentibacter pneumotropicus—A New Method for the Generation of Bacterial Vaccines with Increased Efficacy
por: Fertey, Jasmin, et al.
Publicado: (2020)

Factors That Influence Sustained Release from Hot-Melt Extrudates
por: Mansuroglu, Yaser, et al.
Publicado: (2023)

Pathogens Inactivated by Low-Energy-Electron Irradiation Maintain Antigenic Properties and Induce Protective Immune Responses
por: Fertey, Jasmin, et al.
Publicado: (2016)

Low Energy Electron Irradiation Is a Potent Alternative to Gamma Irradiation for the Inactivation of (CAR-)NK-92 Cells in ATMP Manufacturing
por: Walcher, Lia, et al.
Publicado: (2021)

Mucosal Immune Responses to Respiratory Syncytial Virus
por: Barnes, Megan V. C., et al.
Publicado: (2022)

TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection
por: Pearson, Hayley, et al.
Publicado: (2021)

Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases
por: Grunwald, Thomas, et al.
Publicado: (2015)

Inactivation of respiratory syncytial virus by zinc finger reactive compounds
por: Boukhvalova, Marina S, et al.
Publicado: (2010)

Nasal mucosal microRNA expression in children with respiratory syncytial virus infection
por: Inchley, Christopher S, et al.
Publicado: (2015)

Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus
por: Killikelly, April M., et al.
Publicado: (2016)

Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf
por: McGill, Jodi L., et al.
Publicado: (2018)

131. The Protective Role of Mucosal Interferons in Infants with Respiratory Syncytial Virus (RSV) Infection
por: Taveras, Jeanette, et al.
Publicado: (2020)

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
por: Lapuente, Dennis, et al.
Publicado: (2021)

Dual Role of Respiratory Syncytial Virus Glycoprotein Fragment as a Mucosal Immunogen and Chemotactic Adjuvant
por: Kim, Sol, et al.
Publicado: (2012)

Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV
por: Derscheid, Rachel J., et al.
Publicado: (2013)

Ozone inactivation of airborne influenza and lack of resistance of respiratory syncytial virus to aerosolization and sampling processes
por: Dubuis, Marie-Eve, et al.
Publicado: (2021)

Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine
por: Falsey, Ann R, et al.
Publicado: (2021)

A Recombinant Zika Virus Envelope Protein with Mutations in the Conserved Fusion Loop Leads to Reduced Antibody Cross-Reactivity upon Vaccination
por: Berneck, Beatrice Sarah, et al.
Publicado: (2020)

Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice
por: Resch, Theresa K., et al.
Publicado: (2018)

Caspase-1 Independent Viral Clearance and Adaptive Immunity Against Mucosal Respiratory Syncytial Virus Infection
por: Shim, Ye Ri, et al.
Publicado: (2015)

Immunization with different recombinant West Nile virus envelope proteins induces varying levels of serological cross-reactivity and protection from infection
por: Weiß, Rebecca, et al.
Publicado: (2023)

High pneumococcal density correlates with more mucosal inflammation and reduced respiratory syncytial virus disease severity in infants
por: Vissers, Marloes, et al.
Publicado: (2016)

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame
por: Parker, Edward PK, et al.
Publicado: (2015)

Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case study
por: Walker, Richard I., et al.
Publicado: (2023)

Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine
por: Russell, Marsha S., et al.
Publicado: (2019)

Protection against Bovine Respiratory Syncytial Virus Afforded by Maternal Antibodies from Cows Immunized with an Inactivated Vaccine
por: Meyer, Gilles, et al.
Publicado: (2023)

Mucosal Injuries due to Ribosome-Inactivating Stress and the Compensatory Responses of the Intestinal Epithelial Barrier
por: Moon, Yuseok
Publicado: (2011)

PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine
por: Rioux, Gervais, et al.
Publicado: (2014)

Effect of inactivated Streptococcus pneumoniae as non-pathogenic particles on the severity of pneumonia caused by respiratory syncytial virus infection in mice
por: Miyauchi, Aki, et al.
Publicado: (2019)

A single vaccination with an inactivated bovine respiratory syncytial virus vaccine primes the cellular immune response in calves with maternal antibody
por: van der Sluijs, Mirjam TW, et al.
Publicado: (2010)

79. Mucosal Interferon (IFN) Responses in Infants with Respiratory Syncytial Virus (RSV) Infection to Inform Live Attenuated Vaccine (LAV) Development
por: Taveras, Jeanette, et al.
Publicado: (2019)

Ribosomal Alteration-Derived Signals for Cytokine Induction in Mucosal and Systemic Inflammation: Noncanonical Pathways by Ribosomal Inactivation
por: Moon, Yuseok
Publicado: (2014)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

1186. Increased Respiratory Syncytial Virus (RSV) Viral Replication Leads to Increased Cytokine Production and Polarized Interferon Response in Infant Mucosal Epithelium
por: Glowinski, Rebecca M, et al.
Publicado: (2021)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_dgt8mu5pors9j2a2djt1cumff0